UNSPSC 51453105: Morantel tartrate

This classification denotes an antihelminthic agent with the molecular formula C12H16N2S.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5WF7E9QC3F. The term morantel tartrate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule morantel tartrate under HS 29349990 and SITC 51579. As of Q4 2014, MORANTEL TARTRATE remains US FDA's Preferred Term for this commodity. Morantel tartrate bears US NLM identifiers UMLS ID C0026535 and NCI Concept Code C75222.

SMILES: CC1CCSC1/C=C/C2=NCCCN2C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51453105 Morantel tartrate is a Commodity code identifying a specific antiparasitic pharmaceutical active ingredient, yet recent state and local procurement activity under this code does not reflect morantel tartrate procurement directly. The two opportunities posted in the recent-opportunities block involve related pharmaceutical products — an Illinois Department of Public Health piggyback warehouse order for doxycycline and ciprofloxacin, and a Seminole County, Florida IFB for naloxone and drug deactivation systems — neither of which is morantel tartrate. State and local health departments, county health authorities, and public health agencies appear to use this code tier for episodic pharmaceutical acquisitions tied to disease prevention, emergency preparedness, or opioid response initiatives, but the actual purchasing activity diverges significantly from the code's nominal product scope.

Activity under this code is geographically dispersed across Florida and Illinois based on recent postings, with no clear pattern of repeat buying in a single jurisdiction. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026, under IFB 26482DPHPREPDB53392, and Seminole County, Florida issued an IFB (60459723LAS) on June 30, 2026, for annual supplies of naloxone and drug deactivation systems with quarterly deliveries, though that opportunity's due date of July 26, 2023, appears to be a historical record. The code shows minimal recent morantel tartrate–specific solicitation activity among state and local buyers.